Brian Robb Douglass

Insider Reports History

Location
Waltham, MA
Signature
/s/ Jennifer Carmichael (Attorney in Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Robb Douglass:

Company Role Class Num Shares Value Price $ Report Date Ownership
REPLIGEN CORP CHIEF PRODUCT OFFICER Common Stock 8,319 $1,039,625 $124.97 02 Mar 2026 Direct
REPLIGEN CORP CHIEF PRODUCT OFFICER Stock Option (Right to Buy) 2,143 31 Dec 2025 Direct

Insider Reports Filed by Brian Robb Douglass

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGEN REPLIGEN CORP 02 Mar 2026 1 -$27,618 4 CHIEF PRODUCT OFFICER 03 Mar 2026, 12:48
RGEN REPLIGEN CORP 31 Dec 2025 2 $0 4 CHIEF PRODUCT OFFICER 12 Jan 2026, 16:32
RGEN REPLIGEN CORP 31 Dec 2025 0 $0 3 CHIEF PRODUCT OFFICER 12 Jan 2026, 16:30